Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Metabolic approaches to antihypertensive treatment in diabetic patients

Metabolic approaches to antihypertensive treatment in diabetic patients Hypertension Research (2015) 38, 802–803 & 2015 The Japanese Society of Hypertension All rights reserved 0916-9636/15 www.nature.com/hr COMMENTARY Metabolic approaches to antihypertensive treatment in diabetic patients Arrigo F Cicero and Giuliano Tocci Hypertension Research (2015) 38, 802–803; doi:10.1038/hr.2015.105; published online 1 October 2015 ypertension management and control combination therapies, based on the use recommended by guidelines to be used in His still a major clinical challenge. of two or three pharmacological agents hypertensive patients at metabolic risk or in Despite the availability of modern diagnostic able to provide greater systolic/diastolic BP those with metabolic abnormalities, to pre- noninvasive options and effective, sustained reductions than each component used in vent development or reduce progression and well-tolerated pharmacological strategies, monotherapy and possibly additional, toward diabetes and its complications. pleiotropic beneficial effects on metabolic Finally, the proposed strategies are also the observational studies and national registries parameters. In particular, current guidelines one most used in clinical practice. have being continuously reported relatively recommended the use of combination At the end of the observation period, both poor rates of blood pressure (BP) control at therapies based on renin-angiotensin system treatments produced effective BP reductions, both national and local levels. Several poten- blocking agents, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Hypertension Research Springer Journals

Metabolic approaches to antihypertensive treatment in diabetic patients

Hypertension Research , Volume 38 (12) – Oct 1, 2015

Loading next page...
 
/lp/springer-journals/metabolic-approaches-to-antihypertensive-treatment-in-diabetic-7Nxa0xNvcE

References (14)

Publisher
Springer Journals
Copyright
Copyright © 2015 by The Japanese Society of Hypertension
Subject
Medicine & Public Health; Medicine/Public Health, general; Internal Medicine; Public Health; Geriatrics/Gerontology; Obstetrics/Perinatology/Midwifery; Health Promotion and Disease Prevention
ISSN
0916-9636
eISSN
1348-4214
DOI
10.1038/hr.2015.105
Publisher site
See Article on Publisher Site

Abstract

Hypertension Research (2015) 38, 802–803 & 2015 The Japanese Society of Hypertension All rights reserved 0916-9636/15 www.nature.com/hr COMMENTARY Metabolic approaches to antihypertensive treatment in diabetic patients Arrigo F Cicero and Giuliano Tocci Hypertension Research (2015) 38, 802–803; doi:10.1038/hr.2015.105; published online 1 October 2015 ypertension management and control combination therapies, based on the use recommended by guidelines to be used in His still a major clinical challenge. of two or three pharmacological agents hypertensive patients at metabolic risk or in Despite the availability of modern diagnostic able to provide greater systolic/diastolic BP those with metabolic abnormalities, to pre- noninvasive options and effective, sustained reductions than each component used in vent development or reduce progression and well-tolerated pharmacological strategies, monotherapy and possibly additional, toward diabetes and its complications. pleiotropic beneficial effects on metabolic Finally, the proposed strategies are also the observational studies and national registries parameters. In particular, current guidelines one most used in clinical practice. have being continuously reported relatively recommended the use of combination At the end of the observation period, both poor rates of blood pressure (BP) control at therapies based on renin-angiotensin system treatments produced effective BP reductions, both national and local levels. Several poten- blocking agents,

Journal

Hypertension ResearchSpringer Journals

Published: Oct 1, 2015

There are no references for this article.